SynthesisAdvances in therapy2024

Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review.

Xiaotian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.